Evaluation of the role of vitamin D in patients with psoriasis

Detalhes bibliográficos
Autor(a) principal: Pedon, Isabel Caroline Zanatta
Data de Publicação: 2023
Outros Autores: Fim , Gabriela Martins, Libera, Nathalia Kaminski Della, Mattos , Alexandra Brugnera Nunes de
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Research, Society and Development
Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/43929
Resumo: Objectives: Investigate whether there is any association between the levels of vitamin D in the blood and the seriousness of psoriasis or its development. Methods: The study is characterized as observational, retrospective, composed of 40 patients with psoriasis who had serum vitamin D levels, who underwent clinical care at a dermatology outpatient clinic in Passo Fundo/RS, from August 2019 to June 2021.  Results: Of the 40 interviewees, 60% were female and 40% male. Phototypes II and III prevailed. Regarding family health history, 50% had a history of the disease. Regarding the duration of psoriasis, the predominant group was between 1-10 years (57.5%). The most prevalent psoriasis subtype was vulgaris (62.5%). Regarding serum vitamin D results, the lowest index was 15.2 ng ̸ mL, the highest was 42.3 ng ̸ mL and the average was 25.99 ng ̸mL. In the predominant age group, between 20-40 years, the proportion of patients with vitamin D was less than 30 ng ̸mL is 83.33%. The lower the phototype, the greater the proportion of patients with suboptimal serum vitamin D. In the group of patients with disease duration > 10 years, vitamin D levels were lower. There is no extreme difference in the effectiveness of treatments when analyzing the average, minimum and maximum serum levels of vitamin D. Conclusion: There was no relationship between serum levels of 25-hydroxyvitamin D (25OHD) and the development of psoriasis or even control – worsening of the clinical picture of disease.
id UNIFEI_90333af094469477bdeb0d942b8db99a
oai_identifier_str oai:ojs.pkp.sfu.ca:article/43929
network_acronym_str UNIFEI
network_name_str Research, Society and Development
repository_id_str
spelling Evaluation of the role of vitamin D in patients with psoriasis Evaluación del papel de la vitamina D en pacientes con psoriasisAvaliação do papel da vitamina D em pacientes com psoríasePsoriasisVitamina DSistema inmunológico.PsoriasisVitamin DImmune system.PsoríaseVitamina DSistema imune.Objectives: Investigate whether there is any association between the levels of vitamin D in the blood and the seriousness of psoriasis or its development. Methods: The study is characterized as observational, retrospective, composed of 40 patients with psoriasis who had serum vitamin D levels, who underwent clinical care at a dermatology outpatient clinic in Passo Fundo/RS, from August 2019 to June 2021.  Results: Of the 40 interviewees, 60% were female and 40% male. Phototypes II and III prevailed. Regarding family health history, 50% had a history of the disease. Regarding the duration of psoriasis, the predominant group was between 1-10 years (57.5%). The most prevalent psoriasis subtype was vulgaris (62.5%). Regarding serum vitamin D results, the lowest index was 15.2 ng ̸ mL, the highest was 42.3 ng ̸ mL and the average was 25.99 ng ̸mL. In the predominant age group, between 20-40 years, the proportion of patients with vitamin D was less than 30 ng ̸mL is 83.33%. The lower the phototype, the greater the proportion of patients with suboptimal serum vitamin D. In the group of patients with disease duration > 10 years, vitamin D levels were lower. There is no extreme difference in the effectiveness of treatments when analyzing the average, minimum and maximum serum levels of vitamin D. Conclusion: There was no relationship between serum levels of 25-hydroxyvitamin D (25OHD) and the development of psoriasis or even control – worsening of the clinical picture of disease.Objetivos: Investigar la asociación entre los niveles séricos de vitamina D y el pronóstico de la enfermedad. Métodos: Se trata de un estudio observacional y retrospectivo de 40 pacientes con psoriasis que tenían niveles séricos de vitamina D y fueron atendidos en um ambulatorio de dermatología en Passo Fundo/RS, entre agosto de 2019 y junio de 2021. Resultados: De los 40 entrevistados, el 60% eran mujeres y el 40% hombres. Predominaron los fototipos II y III. En cuanto a la duración de la psoriasis, el grupo predominante fue entre 1-10 años (57,5%). El subtipo de psoriasis más prevalente fue la vulgaris (62,5%). El nivel sérico de vitamina D más bajo fue de 15,2 ng ̸ mL, el más alto de 42,3 ng ̸ mL y la media de 25,99 ng ̸ mL. En el grupo de edad predominante entre 20-40 años, la proporción de pacientes con vitamina D inferior a 30 ng ̸mL es del 83,33%. Cuanto menor es el fototipo, mayor es la proporción de pacientes con vitamina D sérica inferior a la ideal. En el grupo de pacientes con duración de la enfermedad > 10 años, los niveles de vitamina D fueron inferiores. No hubo diferencias extremas en la eficacia de los tratamientos cuando se analizaron los niveles séricos medios, mínimos y máximos de vitamina D. Conclusión: No se observó ninguna relación entre los niveles séricos de 25-hidroxivitamina D (25OHD) y el desarrollo de psoriasis o incluso el pronóstico de la enfermedad.Objetivos: Investigar se há associação entre os níveis séricos de vitamina D e a gravidade da psoríase ou mesmo o seu desenvolvimento. Métodos: O estudo caracteriza-se como observacional, retrospectivo, composto por 40 pacientes com psoríase que apresentavam dosagem sérica de vitamina D e que foram atendidos em um ambulatório de dermatologia de Passo Fundo ̸RS, no período agosto de 2019 a junho de 2021. Resultados: Dos 40 entrevistados, 60% eram do sexo feminino e 40% do sexo masculino. Prevaleceram os fototipos II e III. Referente ao histórico familiar, 50% tinha histórico da doença. Sobre a duração da psoríase, o grupo predominante foi entre 1-10 anos (57,5%). O subtipo de psoríase mais prevalente foi a vulgar (62,5%). Em relação aos resultados de vitamina D sérica, o menor índice foi 15,2 ng ̸ mL, o maior foi 42,3 ng ̸ mL e a média foi 25,99 ng ̸ mL. Na faixa etária predominante, entre 20-40 anos, a proporção de pacientes com vitamina D menor que 30 ng ̸mL é de 83,33%. Quanto menor o fototipo, maior a proporção de pacientes com vitamina D sérico abaixo do ideal. No grupo de pacientes com duração da doença > 10 anos, o nível de vitamina D apresentou-se mais baixo. Não há diferença extrema quanto a eficácia dos tratamentos ao analisar a média, mínimos e máximos de níveis séricos de vitamina D. Conclusão: Não houve relação dos níveis séricos de 25-hidroxivitamina D (25OHD) e o desenvolvimento da psoríase ou mesmo do prognóstico da doença.Research, Society and Development2023-11-18info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/4392910.33448/rsd-v12i12.43929Research, Society and Development; Vol. 12 No. 12; e100121243929Research, Society and Development; Vol. 12 Núm. 12; e100121243929Research, Society and Development; v. 12 n. 12; e1001212439292525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIenghttps://rsdjournal.org/index.php/rsd/article/view/43929/35334Copyright (c) 2023 Isabel Caroline Zanatta Pedon; Gabriela Martins Fim ; Nathalia Kaminski Della Libera; Alexandra Brugnera Nunes de Mattos https://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessPedon, Isabel Caroline Zanatta Fim , Gabriela Martins Libera, Nathalia Kaminski Della Mattos , Alexandra Brugnera Nunes de 2023-11-24T09:58:06Zoai:ojs.pkp.sfu.ca:article/43929Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2023-11-24T09:58:06Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false
dc.title.none.fl_str_mv Evaluation of the role of vitamin D in patients with psoriasis
Evaluación del papel de la vitamina D en pacientes con psoriasis
Avaliação do papel da vitamina D em pacientes com psoríase
title Evaluation of the role of vitamin D in patients with psoriasis
spellingShingle Evaluation of the role of vitamin D in patients with psoriasis
Pedon, Isabel Caroline Zanatta
Psoriasis
Vitamina D
Sistema inmunológico.
Psoriasis
Vitamin D
Immune system.
Psoríase
Vitamina D
Sistema imune.
title_short Evaluation of the role of vitamin D in patients with psoriasis
title_full Evaluation of the role of vitamin D in patients with psoriasis
title_fullStr Evaluation of the role of vitamin D in patients with psoriasis
title_full_unstemmed Evaluation of the role of vitamin D in patients with psoriasis
title_sort Evaluation of the role of vitamin D in patients with psoriasis
author Pedon, Isabel Caroline Zanatta
author_facet Pedon, Isabel Caroline Zanatta
Fim , Gabriela Martins
Libera, Nathalia Kaminski Della
Mattos , Alexandra Brugnera Nunes de
author_role author
author2 Fim , Gabriela Martins
Libera, Nathalia Kaminski Della
Mattos , Alexandra Brugnera Nunes de
author2_role author
author
author
dc.contributor.author.fl_str_mv Pedon, Isabel Caroline Zanatta
Fim , Gabriela Martins
Libera, Nathalia Kaminski Della
Mattos , Alexandra Brugnera Nunes de
dc.subject.por.fl_str_mv Psoriasis
Vitamina D
Sistema inmunológico.
Psoriasis
Vitamin D
Immune system.
Psoríase
Vitamina D
Sistema imune.
topic Psoriasis
Vitamina D
Sistema inmunológico.
Psoriasis
Vitamin D
Immune system.
Psoríase
Vitamina D
Sistema imune.
description Objectives: Investigate whether there is any association between the levels of vitamin D in the blood and the seriousness of psoriasis or its development. Methods: The study is characterized as observational, retrospective, composed of 40 patients with psoriasis who had serum vitamin D levels, who underwent clinical care at a dermatology outpatient clinic in Passo Fundo/RS, from August 2019 to June 2021.  Results: Of the 40 interviewees, 60% were female and 40% male. Phototypes II and III prevailed. Regarding family health history, 50% had a history of the disease. Regarding the duration of psoriasis, the predominant group was between 1-10 years (57.5%). The most prevalent psoriasis subtype was vulgaris (62.5%). Regarding serum vitamin D results, the lowest index was 15.2 ng ̸ mL, the highest was 42.3 ng ̸ mL and the average was 25.99 ng ̸mL. In the predominant age group, between 20-40 years, the proportion of patients with vitamin D was less than 30 ng ̸mL is 83.33%. The lower the phototype, the greater the proportion of patients with suboptimal serum vitamin D. In the group of patients with disease duration > 10 years, vitamin D levels were lower. There is no extreme difference in the effectiveness of treatments when analyzing the average, minimum and maximum serum levels of vitamin D. Conclusion: There was no relationship between serum levels of 25-hydroxyvitamin D (25OHD) and the development of psoriasis or even control – worsening of the clinical picture of disease.
publishDate 2023
dc.date.none.fl_str_mv 2023-11-18
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/43929
10.33448/rsd-v12i12.43929
url https://rsdjournal.org/index.php/rsd/article/view/43929
identifier_str_mv 10.33448/rsd-v12i12.43929
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/43929/35334
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Research, Society and Development
publisher.none.fl_str_mv Research, Society and Development
dc.source.none.fl_str_mv Research, Society and Development; Vol. 12 No. 12; e100121243929
Research, Society and Development; Vol. 12 Núm. 12; e100121243929
Research, Society and Development; v. 12 n. 12; e100121243929
2525-3409
reponame:Research, Society and Development
instname:Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
instname_str Universidade Federal de Itajubá (UNIFEI)
instacron_str UNIFEI
institution UNIFEI
reponame_str Research, Society and Development
collection Research, Society and Development
repository.name.fl_str_mv Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)
repository.mail.fl_str_mv rsd.articles@gmail.com
_version_ 1797052633705349120